Potential Markers for Detection and Monitoring of Ovarian Cancer
Author Information
Author(s): Brandon J. D. Rein, Sajal Gupta, Rima Dada, Joelle Safi, Chad Michener, Ashok Agarwal
Primary Institution: Cleveland Clinic
Hypothesis
Improved detection at early stages of ovarian cancer is needed to enhance survival rates.
Conclusion
The study suggests that novel biomarkers and combination panels may lead to effective screening strategies for early detection of ovarian cancer.
Supporting Evidence
- Current screening approaches include tumor markers and ultrasound.
- HE4 and mesothelin can improve the detection of ovarian cancer.
- Early diagnosis can improve five-year survival rates to over 90%.
- CA125 is widely used but has limitations in early-stage detection.
Takeaway
Scientists are looking for better ways to find ovarian cancer early so that more people can be treated successfully.
Methodology
A comprehensive literature review was performed in PubMed and other sources to identify relevant studies on ovarian cancer biomarkers.
Limitations
The study highlights challenges in early detection and the need for more research on biomarkers.
Participant Demographics
The study included various populations, focusing on women at risk for ovarian cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website